QTTB · Q32 Bio Inc. · Executive Compensation
Market Cap
$257.51M
Shares
29.77M
Volume · Oct 26
563.7K
Avg daily vol (3M)
711.36K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jodie Morrison | Chief Executive Officer and Director | $1,558,870 |
| Lee Kalowski | Chief Financial Officer and President | $987,147 |
| Shelia Violette | Chief Scientific Officer | $774,446 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jodie Morrison | Chief Executive Officer and Director | $6,003,238 |
| Lee Kalowski | Chief Financial Officer and President | $2,854,009 |
| Jason Campagna | M.D., Ph.D. Chief Medical Officer | $1,549,488 |
| Paul Alloway | Ph.D., J.D. Former President, Chief Operating Officer and Secretary | $758,139 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jodie Morrison | Chief Executive Officer and Director | $1,075,907 |
| Paul Alloway | Ph.D., J.D. Former President, Chief Operating Officer and Secretary | $786,463 |
| Jason Campagna | M.D., Ph.D. Chief Medical Officer | $680,927 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Arthur Tzianabos | Chairman of the Board and former Chief Executive Officer | $1,672,061 |
| Albert Seymour | Chief Executive Officer | $1,197,487 |
| W. Bradford Smith | Chief Financial and Business Officer and Treasurer | $994,251 |
| Paul Alloway | Ph.D., J.D. Chief Legal Officer and Secretary | $868,639 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Arthur Tzianabos | Chairman of the Board and former Chief Executive Officer | $3,607,339 |
| W. Bradford Smith | Chief Financial and Business Officer and Treasurer | $2,047,779 |
| Albert Seymour | Chief Executive Officer | $1,467,658 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Arthur Tzianabos | President and Chief Executive Officer | $885,960 |
| Albert Seymour | Chief Scientific Officer | $607,577 |
| W. Bradford Smith | Chief Financial Officer | $582,380 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Arthur Tzianabos | President and Chief Executive Officer | $5,062,877 |
| Albert Seymour | Chief Scientific Officer | $1,876,827 |
| W. Bradford Smith | Chief Financial Officer | $1,860,296 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Arthur Tzianabos | President and Chief Executive Officer | $4,313,115 |
| Albert Seymour | Chief Scientific Officer | $2,123,757 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Adrien Sipos, M.D., Ph.D. | Interim Chief Medical Officer | Appointed | 2025-06-25 |
| Jason Campagna, M.D., Ph.D. | Chief Medical Officer | Resigned | 2025-06-25 |
| Mark Iwicki | member of the board of directors | Resigned | 2025-04-25 |
| Charles Michaud, Jr. | Vice President, Corporate Controller and Treasurer and principal financial officer and principal accounting officer | Resigned | 2024-03-27 |
| Paul Alloway | President, Chief Operating Officer and Secretary and principal executive officer | Resigned | 2024-03-27 |
| Bill Lundberg | Class III director | Appointed | 2024-03-27 |
| Kathleen LaPorte | Class II director | Appointed | 2024-03-27 |
| Mary Thistle | Class III director | Appointed | 2024-03-27 |
| Diyong Xu | Class I director | Appointed | 2024-03-27 |
| Arthur Tzianabos | Class II director | Appointed | 2024-03-27 |
| Isaac Manke | Class I director | Appointed | 2024-03-27 |
| David Grayzel | Class I director | Appointed | 2024-03-27 |
| Paul Alloway | President, Chief Operating Officer and Secretary and principal executive officer | Resigned | 2024-03-27 |
| Charles Michaud, Jr. | Vice President, Corporate Controller and Treasurer and principal financial officer and principal accounting officer | Resigned | 2024-03-27 |
| Mark Iwicki | Chairperson of the Board | Appointed | 2024-03-27 |
| Shelia Violette | Chief Scientific Officer and President of Research | Appointed | 2024-03-27 |
| Jason Campagna | Chief Medical Officer | Appointed | 2024-03-27 |
| Lee Kalowski | Chief Financial Officer and President | Appointed | 2024-03-27 |
| Jodie Morrison | Chief Executive Officer | Appointed | 2024-03-27 |
| Jodie Morrison | member of the Board | Appointed | 2024-03-27 |
| Jeffrey V. Poulton | Board | Resigned | 2024-03-27 |
| Matthew R. Patterson | Board | Resigned | 2024-03-27 |
| Alise S. Reicin | Board | Resigned | 2024-03-27 |
| Steven Gillis | Board | Resigned | 2024-03-27 |
| Charles Michaud, Jr. | principal accounting officer | Appointed | 2023-11-16 |
Leadership
- Albert Seymour, Ph.D. CEO, Board Member
- Jodie Morrison CEO, Board Member
- Paul G. Alloway, Ph.D. CEO, COO
- Tim Kelly CEO, COO
- Arthur O. Tzianabos, Ph.D. Chairman
- Mark Iwicki Chairman
- Charles Michaud, Jr. CFO, Chief Accounting Officer
- Lee Kalowski CFO
- Arthur Tzianabos Board Member
- Bill Lundberg Board Member
- Jeffrey V. Poulton Board Member
- Kathleen LaPorte Board Member